DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)

DongKoo Bio & Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2017
Period Ending	Feb 20, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2017
Market Capitalization	137,601	156,349	169,609	232,556	240,580	-
Market Cap Growth	7.07%	-7.82%	-27.07%	-3.34%	-	-
Enterprise Value	179,474	172,036	175,056	221,869	244,593	-
Last Close Price	5040.00	5660.00	6009.59	7906.48	7931.13	-
PE Ratio	9.02	13.24	25.64	24.93	26.32	-
PS Ratio	0.55	0.72	0.87	1.50	1.73	-
PB Ratio	1.19	1.42	1.66	2.32	2.54	-
P/TBV Ratio	1.55	1.57	1.82	2.40	2.60	-
P/FCF Ratio	-	-	14.32	17.05	108.33	-
P/OCF Ratio	8.23	43.61	10.08	12.99	32.13	-
EV/Sales Ratio	0.71	0.80	0.90	1.43	1.76	-
EV/EBITDA Ratio	8.35	8.33	7.79	16.82	20.19	-
EV/EBIT Ratio	12.11	11.77	10.40	27.26	32.13	-
EV/FCF Ratio	-25.08	-	14.78	16.27	110.14	-
Debt / Equity Ratio	0.66	0.40	0.34	0.24	0.25	0.40
Debt / EBITDA Ratio	3.04	2.12	1.53	1.84	1.96	0.97
Debt / FCF Ratio	-	-	2.90	1.78	10.69	1.73
Asset Turnover	1.21	1.19	1.19	1.04	-	1.44
Inventory Turnover	2.40	2.26	2.74	2.52	-	3.54
Quick Ratio	0.54	0.60	0.83	0.97	1.16	0.93
Current Ratio	0.99	1.21	1.32	1.48	1.79	1.29
Return on Equity (ROE)	13.85%	11.11%	6.54%	9.58%	-	35.35%
Return on Assets (ROA)	5.40%	5.03%	6.44%	3.40%	-	11.83%
Return on Capital (ROIC)	6.78%	6.29%	8.07%	4.19%	-	17.28%
Return on Capital Employed (ROCE)	13.45%	12.41%	15.88%	7.77%	7.33%	32.53%
Earnings Yield	11.15%	7.55%	3.90%	4.01%	3.80%	-
FCF Yield	-5.20%	-6.56%	6.98%	5.86%	0.92%	-
Dividend Yield	2.38%	2.12%	-	-	-	-
Payout Ratio	21.60%	25.72%	42.39%	10.11%	10.32%	-
Buyback Yield / Dilution	0.73%	0.48%	1.78%	0.12%	-25.96%	20.35%
Total Shareholder Return	3.12%	2.60%	1.78%	0.12%	-25.96%	20.35%

Source: S&P Capital IQ. Standard template. Financial Sources.